$13.9 Million Approved for Sickle Cell Research at UCLA
The California stem cell agency today effectively approved a $13.9 million grant involving UCLA to develop stem cell gene therapy for sickle cell anemia.
CIRM directors acted on a staff recommendation to place the grant in a category that is automatically approved by the board.
(Here is a press release that was issued later by UCLA. The investigator is Do…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.